WORKING WITH US
Harnessing nearly two decades of experience, The Chase Group, Inc. offers standard-setting professional recruitment services in the Life Sciences industry. Because we work exclusively in the substantive areas of global pharmaceuticals, biotechnology, academic medicine and research, non-profits, animal health, diagnostics, medical devices and healthcare communications, our executive recruiters are focused strictly on identifying, targeting and securing the highest quality candidates skilled for these unique markets. By maintaining an extensive network of strategic contacts specific to the Life Sciences industry, The Chase Group can deliver responsive, timely and cost-effective recruitment solutions that meet our clients’ and candidates’ specialized needs.
FINDING A CANDIDATE
Dedication, keen industry insight, individualized service and a competitive spirit unite in The Chase Group’s proprietary approach to recruitment, enabling us to effectively and efficiently secure the high-caliber candidates our clients require.
SECURING A NEW POSITION
Much more than just an executive search firm directory, The Chase Group offers individualized services for both clients and candidates, ensuring that skills, qualifications and personalities are a precise match. For us and for our candidates, each placement signifies more than a job—it may reflect the beginning of an enduring career or the next critical step in one’s professional evolution.
"Find a job you love and never work another day in your life..."
Jun 16, 2015
The Chase Group Fills Chief Medical Officer Role at Esperion Therapeutics
The Chase Group is proud to announce the successful completion of a search for a Chief Medical Officer for Esperion Therapeutics with the hiring of Dr. Mary McGowan. Dr. McGowan will oversee the overall direction, planning execution and interpretation of clinical development, medical and regulatory...
Jun 12, 2015
AstraZeneca Neuroscience iMed Retains The Chase Group for Chief Medical Officer Position
The Chase Group has been retained to conduct a search to identify an industry physician to serve as the Chief Medical Officer/Head of Early Clinical Development of AZ’s “Virtual” Neuroscience Innovative Medicines Unit. The CMO will serve as a member of the Neuroscience iMed Leadership Team and will...
Jun 1, 2015
Chief Business Officer Secured for Entasis Therapeutics
The Chase Group proudly announces the completion of a search for the Chief Business Officer for Entasis Therapeutics, a wholly-owned subsidiary of AstraZeneca. Completed within 60 days, the search culminated in the placement of an industry leader with significant experience that will allow the...
May 25, 2015
Executive Director of Drug Safety
May 18, 2015
Akcea Therapeutics Begins Search for Chief Medical Officer
Akcea Therapeutics has retained The Chase Group to secure a Chief Medical Officer to join the start-up organization. This person will be responsible for the overall strategic direction for development products and programs across all stages of development. These responsibilities will cover the full...
Apr 21, 2015
Entasis Therapeutics Retains The Chase Group for Chief Medical Officer Position
Entasis Therapeutics has retained The Chase Group to secure a Chief Medical Officer responsible for the overall direction, planning, execution and interpretation of medical affairs, regulatory affairs and clinical research programs implemented by the company. He/she will 1) oversee the development...
Apr 1, 2015
AbbVie Global Regulatory Affairs and TCG Partner Once Again!
AbbVie has retained The Chase Group to secure a Director of Global Regulatory Strategy! AbbVie is committed to adding exceptional regulatory professionals to its Global Product Strategy team and has a strong pipeline in all phases of development to meet the needs of the right candidate. This newly...
Feb 18, 2015
Esperion Therapeutics Partners with The Chase Group
Esperion Therapeutics has retained The Chase Group to secure a Chief Medical Officer responsible for the overall direction, planning, execution and interpretation of clinical research and development programs and medical affairs implemented by Esperion. Potential candidates should contact Joyce...
Jan 12, 2015
Ipsen VP Neurology Franchise Secured
The Chase Group is proud to announce they recently completed a search for Vice President, Neurology Franchise for Ipsen US. Donald Pearl has been hired to spearhead leadership of sales and marketing for current and future products.
Jan 12, 2015
RRD International Retains The Chase Group
RRD International has retained The Chase Group to secure a Chief Development Officer to direct and manage the day-to-day activities of all RRD International product development staff and functions. Potential candidates should contact Joyce at 913.663.3100.